Please login to the form below

Not currently logged in
Email:
Password:

Perrigo appoints Gerresheimer’s Uwe Rohrhoff as CEO

He succeeds John Hendrickson, who resigns as CEO and board member

Generic pharmaceutical company Perrigo has appointed Uwe Rohrhoff, Gerresheimer’s former chief executive officer, as its new CEO.

Rohrhoff will succeed John Hendrickson, who resigns as both the Dublin-headquartered company's CEO and a member of its board.

The appointment has been one of a few changes at the company, just last year Perrigo’s chief financial officer Judy Brown stepped down from her role to join Amgen, and Ronald Winowiecki was appointed acting CFO.

Perrigo said that it suspended its search for a replacement CFO during its search for Hendrickson’s successor as CEO.

17th January 2018

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Pandemic preparedness
The pandemic preparedness paradox
Why our efficient ‘just in time’ mentality must be replaced with a resilient ‘just in case’ activity...
Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...

Infographics